Heart recovery after heart attack with added protein therapy
Part of Heart & circulation clinical trials.
This trial tests if adding a protein called rhBNP (which helps the heart relax) to standard care after a heart attack and stent improves heart recovery and pumping strength over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a first-time heart attack that affected the front wall of your heart.
- You got an emergency stent within 12 hours (or later if symptoms continued).
- You are between 18 and 75 years old.
- Your blood pressure after the stent is not too low, and you do not have severe kidney disease or need dialysis.
- You are not pregnant, breastfeeding, or allergic to the study drug (rhBNP, a protein that helps the heart).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a heart medication called recombinant human brain natriuretic peptide (BNP) can help people who are recovering from septic shock. It may improve heart function and reduce the need for other medications.
This study tests whether a medication called nesiritide (a heart-supportive drug) can prevent kidney damage that sometimes occurs after heart surgery with a heart-lung machine. Patients at higher risk for this kidney injury are being enrolled to see if the medication helps protect their kidneys.
This trial tests if adjusting heart failure medications after a valve repair can help people with heart failure and a weak heart pump. It aims to find the best treatment plan to improve outcomes.
This trial tests a balloon pump placed in a heart vein to help the heart recover after a severe heart attack. It is for people who have had an anterior STEMI and need emergency angioplasty.
This trial studies whether sacubitril-valsartan works better than enalapril to improve heart healing after a specific type of heart attack. It aims to see if the heart’s shape and pumping recover more effectively.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
Hear when a new Ventricular Remodeling trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.